Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
Condition:   Leptomeningeal Metastasis Intervention:   Drug: 186RNL Sponsor:   Plus Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2021 Category: Research Source Type: clinical trials